Visiomed Group SA
PAR:ALVMG
Relative Value
The Relative Value of one ALVMG stock under the Base Case scenario is 0.1302 EUR. Compared to the current market price of 0.1804 EUR, Visiomed Group SA is Overvalued by 28%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
ALVMG Competitors Multiples
Visiomed Group SA Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
FR |
Visiomed Group SA
PAR:ALVMG
|
53.1m EUR | 3.9 | 58.8 | 17.3 | 252.3 | ||
US |
Shockwave Medical Inc
NASDAQ:SWAV
|
215.1B USD | 272.9 | 1 315 | 1 243.2 | 1 334.1 | ||
US |
Abbott Laboratories
NYSE:ABT
|
187.1B USD | 4.6 | 33.2 | 19.6 | 29.3 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
148.1B USD | 20.2 | 74.5 | 61.3 | 76.9 | ||
US |
Stryker Corp
NYSE:SYK
|
133.1B USD | 6.3 | 39.6 | 25.6 | 31.5 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
113.4B USD | 7.7 | 64.2 | 32.2 | 47.6 | ||
IE |
Medtronic PLC
NYSE:MDT
|
110.2B USD | 3.4 | 30 | 13.7 | 19.2 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
69.9B USD | 3.5 | 53 | 18.4 | 37.6 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
61.6B EUR | 2.8 | 33.5 | 18.9 | 28 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
53.1B USD | 8.6 | 37.5 | 27.3 | 29.5 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
362.5B CNY | 10.1 | 29.8 | 27.4 | 27.4 |